August 2024

STOCKHOLM, Aug. 22, 2024 /PRNewswire/ — Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce that they have entered into a research collaboration agreement with Eli Lilly and Company (Lilly) to apply the AbiProt®

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: